Marinus Pharmaceuticals, Inc. - Common Stock (MRNS)
0.5332
-0.0004 (-0.07%)
Marinus Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for patients with rare neurological disorders
The company's lead product candidate aims to provide effective treatment options for conditions such as epilepsy. By leveraging their expertise in pharmacology and extensive research, Marinus Pharmaceuticals is dedicated to advancing therapeutic solutions that improve the quality of life for patients suffering from debilitating neurological conditions. Their commitment to innovation and patient care drives their research and development efforts in the field of neurology.
Frequently Asked Questions
Is Marinus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Marinus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Marinus Pharmaceuticals, Inc. - Common Stock trade on?
Marinus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Marinus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Marinus Pharmaceuticals, Inc. - Common Stock is MRNS on the Nasdaq Stock Market
What is the current price of Marinus Pharmaceuticals, Inc. - Common Stock?
The current price of Marinus Pharmaceuticals, Inc. - Common Stock is 0.5332
When was Marinus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Marinus Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on January 7th, 2025
What is the market capitalization of Marinus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Marinus Pharmaceuticals, Inc. - Common Stock is 29.42M
How many shares of Marinus Pharmaceuticals, Inc. - Common Stock are outstanding?
Marinus Pharmaceuticals, Inc. - Common Stock has 55.19M shares outstanding.